Harrow Health, Inc. (HROW)
NASDAQ: HROW · IEX Real-Time Price · USD
10.53
+0.53 (5.30%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Harrow Health Revenue

In the year 2023, Harrow Health had annual revenue of $130.19M with 46.95% growth. Revenue in the quarter ending December 31, 2023 was $36.36M with 78.83% year-over-year growth.

Revenue (ttm)
$130.19M
Revenue Growth
+46.95%
P/S Ratio
2.86
Revenue / Employee
$413,311
Employees
315
Market Cap
372.37M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023130.19M41.60M46.95%
Dec 31, 202288.60M16.12M22.24%
Dec 31, 202172.48M23.61M48.30%
Dec 31, 202048.87M-2.29M-4.48%
Dec 31, 201951.17M9.79M23.67%
Dec 31, 201841.37M14.60M54.52%
Dec 31, 201726.77M6.83M34.26%
Dec 31, 201619.94M10.23M105.25%
Dec 31, 20159.72M8.06M485.30%
Dec 31, 20141.66M1.65M16,500.00%
Dec 31, 201310.00K-90.00K-90.00%
Dec 31, 2012100.00K--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 624.29M
Amarin Corporation 306.91M
Tactile Systems Technology 274.42M
Revance Therapeutics 234.04M
Pacific Biosciences of California 200.52M
Zynex 184.32M
Surmodics 138.20M
Esperion Therapeutics 116.33M
Revenue Rankings